Oliceridine for reducing chronic pain after lung surgery
Treatments studied
Part of Pain clinical trials.
This study tests whether a new pain medication (oliceridine) given through an IV patient-controlled pump can reduce chronic pain after lung surgery. Participants will receive either oliceridine or a standard opioid for pain control after a minimally invasive lung resection. The study will follow patients for several months to see if they develop long-term pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Are between 18 and 75 years old
- Are scheduled for unilateral video-assisted thoracoscopic lung surgery (wedge resection, segmentectomy, lobectomy, or radical resection)
- Have a preoperative pain score of less than 1 on the Numeric Rating Scale
- Are able to understand the study and give written informed consent
- Are expected to recover in the general ward after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two pain medicines given after surgery to see which provides better pain relief with fewer side effects in people who have obstructive sleep apnea. It aims to improve safety and comfort for sleep apnea patients recovering from non-cardiac surgery.
This study tests whether giving the medication dexmedetomidine during and after surgery can prevent long-term pain after a thoracoscopic lung resection. If you are scheduled for this type of lung surgery, you may be able to join and help see if this drug makes recovery less painful over time.
This trial tests if a newer painkiller (oliceridine) causes less nausea after a specific type of brain surgery than the standard painkiller (sufentanil). If you are having CPA region surgery and will receive a patient-controlled pain pump, this study may help find a better option for managing pain with fewer side effects.
This study tests a new pain medicine called oliceridine after laparoscopic upper abdominal surgery. It aims to improve pain control and recovery compared to standard opioids.
This trial tests a new pain medicine called oliceridine for patients recovering from open or laparoscopic abdominal surgery. It aims to see if it works well and is safe for controlling acute pain after the procedure.
This study tests a new painkiller, oliceridine fumarate, given through a pump after lumbar spine surgery. The goal is to see if it helps the bowels and stomach recover faster compared to standard pain relief.
Hear when a new Chronic Postsurgical Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.